M
Medaxion
Biotech & Life Sciences · Nashville, United States · Founded 2008
Anesthesia EHR Software: Electronic Health Records | Medaxion MoreLess
Medaxion operates in the healthcare technology sector, specializing in anesthesia and pharmacy data management. The company provides a comprehensive Electronic Health Record (EHR) platform designed to optimize Operating Room (OR) performance and revenue. Medaxion serves hospitals and health systems by closing information gaps and identifying lost revenue opportunities. Its core products include Medaxion Pulse, an anesthesia EHR platform, Medaxion Sync, which synchronizes multi-source anesthesia data, and Medaxion Advance Pharmacy, which aggregates point-of-care OR drug data. The business model is based on a subscription service, where clients pay for access to the platform and its analytics capabilities. Medaxion generates revenue through these subscriptions and potentially through additional services such as data analytics and consulting. The market it operates in is the healthcare technology industry, specifically focusing on OR efficiency and data management.
Keywords: anesthesia, EHR, OR performance, real-time analytics, healthcare technology, data management, revenue optimization, pharmacy data, hospitals, health systems.
Company overview
Medaxion company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2008
- Headquarters
- Nashville, United States
- Employees
- 50
- Open positions
- None listed
- Dealroom signal
- 63.5
Valuation & funding
Medaxion funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VC✓Equity / VC | Jul 2023 | $20M | $80M | Undisclosed | ↗ |
| EARLY VC✓Equity / VC | May 2018 | $500K | $2M | Undisclosed | — |
| EARLY VC✓Equity / VC | Jul 2016 | $950K | $3.8M | Petra Capital Partners | — |
| EARLY VC✓Equity / VC | Dec 2015 | $970K | $3.9M | Undisclosed | — |
| EARLY VC✓Equity / VC | Jun 2015 | $1.3M | $5.2M | Undisclosed | — |
| EARLY VC✓Equity / VC | Jun 2014 | Undisclosed | — | ||
| SEED✓Equity / VC | Jul 2013 | Undisclosed | — | ||
| SEED✓Equity / VC | Aug 2012 | Undisclosed | — | ||
| SEED✓Equity / VC | Sep 2011 | Undisclosed | — | ||
| SEED✓Equity / VC | Aug 2010 | Undisclosed | — |
Financials
Workforce over time
Available workforce history. Financial fields without reported data are omitted.
| Year | Employees |
|---|---|
| 2026 | 49 |
| 2025 | 52 |
| 2024 | 46 |
Growth signals
Medaxion website traffic
Latest recorded traffic for Medaxion is 3K monthly website visits, up 219.1% over the last three months. Medaxion's team declined 3.8% over the past year.
Comparisons
Medaxion compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Medaxion's talent
Source: Dealroom Talent Intelligence.
Investors
2 investors on Medaxion's cap table
Sourced from Dealroom's funding and investor records.
Global footprint
Where Medaxion has talent and traffic
team presence
In the news
Latest news about Medaxion
Recent press, funding announcements, and product moves mentioning Medaxion — open to read from the original sources.
Market sentiment
What the market is saying about Medaxion
An AI-synthesized read of the highest-engagement posts about Medaxion on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Medaxion’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.